Scientific advice on type F botulism
This report analyses the availability and effectiveness of different types of antitoxins to neutralise type F botulism. A literature review was performed in consultation with the European Medicines Agency.
Rapid Risk Assessment: Wound botulism among people who inject heroin in Norway
At the request of the European Commission, ECDC performed a risk assessment after six cases of wound botulism were reported in Norway among people who had injected heroin. As this is an ongoing problem, some relevant measures are proposed for consideration by other EU/EEA Member States.
Rapid Risk Assessment: Wound botulism in people who inject heroin: Norway and the United Kingdom, 16 February 2015
As of 10 February 2015, 23 cases of botulism have been reported in Norway (eight cases) and Scotland (15 cases), affecting people who inject drugs.
Type E botulism associated with fish product consumption – Germany and Spain, 21 December 2016
This document assesses the risk to human health posed by a multi-country incident of botulism neurotoxin type E, possibly associated with consumption of a commercially-available dried and salted fish product.